Hikma Pharmaceuticals PLC - Mubasher Info
KSA
Mubasher TV
 Contact Us Advertising   العربية
KSA
TDWL Closed
02 April 01:36 AM

Hikma Pharmaceuticals PLC (HIK)

Last update: 20 November 2007 01:44 PM market time.
19.20
-1.25
-6.11%
Open 19.90
Previous Close 20.45
High 19.90
Low 19.20
Stock Statistics
Volume 200
Turnover 3,910.00
All data are 15 minutes late during market session
This mark means that there are news on this date.

Stock

Par Value 0.14 US Dollar
Market Cap 4,506,617,971.20 US Dollar
Book Value (BVPS) 8.55 US Dollar Based on: Fourth Quarter 2018
EPS 0.00 US Dollar Based on: Fourth Quarter 2018
Trading Currency US Dollar

Company Statistics

Current Total Shares 234,719,686
Company Capital 32,860,756.04

News

Hikma Pharmaceuticals signed non-binding deal to acquire GSK Egypt
Hikma Pharmaceuticals allowed to conduct due diligence on GSK Egypt Mergers and Acquisitions
GSK Egypt reported net profits of EGP 101.41 million in nine months
Hikma Pharmaceuticals to acquire majority stake in GSK Egypt Mergers and Acquisitions
The company expect growth in the pharmaceutical sector's revenues
Hikma Pharmaceuticals issues $500m Eurobonds Bonds
Hikma will distribute eleven of Chiesi’s leading products in Egypt
Hikma Pharmaceuticals inks deal to distribute Chiesi’s products in Egypt Companies Investments
Hikma Pharmaceuticals’ investments in the Egyptian market range between $250 million and $300 million
Hikma Pharmaceuticals’ Egypt investments near $300m – MD Companies Investments
U.S. FDA sends warning letter to Hikma Company News
More

Market Announcements

11 March 01:16 PM
Director/PDMR Shareholding
6 March 10:00 AM
Transaction in Own Shares
5 March 10:00 AM
Transaction in Own Shares
4 March 10:00 AM
Transactions in Own Shares
4 March 08:00 AM
Transactions in Own Shares
More